文献速递腹部MR

压缩感知与并行成像用于钆塞酸增强动态肝脏磁共振双动脉期采集

Compressed Sensing and Parallel Imaging for Double Hepatic Arterial Phase Acquisition in Gadoxetate-Enhanced Dynamic Liver Magnetic Resonance Imaging.
PubMed 文献 · Invest Radiol · 2019-01-01

回顾性分析127例患者钆塞酸增强动态肝脏MRI单次屏气双动脉期图像,评估压缩感知联合并行成像(C-SENSE)技术。结果显示AP1+AP2联合评估的最佳动脉期时机比例为90%,显著优于AP2的65%;呼吸运动伪影可忽略比例在AP1+AP2为73%,显著优于AP1的61%和AP2的50%;整体图像质量AP1+AP2优秀比例为54%,显著优于AP1的49%和AP2的39%;病灶检出能力AP1+AP2显著优于单独AP1或AP2。结论认为C-SENSE技术可能有助于实现单次屏气双动脉期成像,获得最佳时机并减少呼吸运动伪影。

要点

  • AP1+AP2联合评估最佳动脉期时机达90%,显著优于AP2的65%(P<0.001)。
  • AP1+AP2呼吸运动伪影可忽略比例为73%,显著优于AP1的61%和AP2的50%(均P<0.001)。
  • AP1+AP2整体图像质量优秀比例为54%,显著优于AP1的49%和AP2的39%(均P<0.001)。

核心结论

  • C-SENSE技术可能有助于在钆塞酸增强动态肝脏MRI中实现单次屏气双动脉期成像,获得最佳时机并减少呼吸运动伪影。

研究设计与样本

  • 回顾性研究,共纳入127例患者(男89例,女38例;平均年龄62.6±7.5岁,范围29-87岁),采用C-SENSE技术行单次屏气双动脉期钆塞酸增强动态肝脏MRI。

关键影像表现/征象

  • AP1最佳动脉期时机为86%,AP2为65%,AP1+AP2为90%,AP1和AP1+AP2均显著优于AP2(均P<0.001)。
  • AP1+AP2呼吸运动伪影可忽略比例为73%,显著优于AP1的61%和AP2的50%(均P<0.001)。
  • AP1+AP2整体图像质量优秀比例为54%,显著优于AP1的49%和AP2的39%(均P<0.001)。
  • 对124个动脉期强化病灶,AP1与AP2检出能力相当,AP1+AP2显著更优。
  • 在62例有既往单动脉期图像的患者中,AP1+AP2的动脉期时机更佳(P=0.004)且呼吸运动伪影更少(P<0.001)。

临床应用与阅片要点

  • 采用C-SENSE技术行单次屏气双动脉期采集时,建议联合判读AP1与AP2图像(AP1+AP2),以优化动脉期时机评估、减少呼吸运动伪影并提高病灶检出。
  • AP2单独图像的最佳动脉期时机比例(65%)和呼吸运动伪影可忽略比例(50%)均低于AP1,阅片时不应单独依赖AP2判断动脉期时机。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to investigate the utility of a combined compressed sensing and parallel imaging (C-SENSE) technique for single breath-hold, double arterial phase (AP) examinations in gadoxetate-enhanced magnetic resonance imaging (MRI) of the liver.

MATERIALS AND METHODS: We retrospectively reviewed single breath-hold, double AP images obtained by using a C-SENSE technique for gadoxetate-enhanced dynamic liver MRI in a total of 127 patients (89 men and 38 women; mean age, 62.6 ± 7.5 [range, 29-87] years). For qualitative analysis, 3 readers independently scored the timing of the AP images, degree of artifacts, and overall image quality on both the first and second AP images (AP1 and AP2, respectively). The combined scores of AP1 and AP2 (AP1 + AP2) were determined by using the better scores from the 2 sets. Focal lesion detectability was assessed for 124 lesions with arterial enhancement on AP1 and AP2, and on simultaneous review of both AP1 and AP2. Then, in 62 patients whose previous gadoxetate-enhanced single AP images were available, AP timing and overall image quality were compared between single and double AP images. Wilcoxon signed rank test was performed for each comparison. Fleiss kappa value was calculated for analysis of interreader agreement.

RESULTS: Optimal AP timing was achieved in 86% of AP1, 65% of AP2, and 90% of AP1 + AP2 images; results were significantly better for AP1 and AP1 + AP2 images than for AP2 images (P < 0.001 for both comparisons). Respiratory motion artifacts were negligible in 73% of the AP1 + AP2 images, which was significantly better than the corresponding values for the AP1 (61%, P < 0.001) or AP2 (50%, P < 0.001) images. Overall image quality was significantly better for AP1 + AP2 (excellent in 54%) than for AP1 (49%, P < 0.001) or AP2 (39%, P < 0.001) images. Lesion detectability was comparable between AP1 and AP2 images and was significantly better on AP1 + AP2. Comparison of single and double AP imaging techniques showed better AP timing (P = 0.004) and fewer respiratory motion artifacts (P < 0.001) for AP1 + AP2 than for the single AP images.

CONCLUSIONS: The C-SENSE technique may facilitate single breath-hold, double AP imaging with optimal timing and reduced respiratory motion artifacts in gadoxetate-enhanced dynamic MRI of the liver.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Yoon JK, Kim MJ, Lee S, et al. Compressed Sensing and Parallel Imaging for Double Hepatic Arterial Phase Acquisition in Gadoxetate-Enhanced Dynamic Liver Magnetic Resonance Imaging. Invest Radiol. 2019. PMID: 30724814. doi:10.1097/RLI.0000000000000548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。